CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue13,003,00011,229,0009,256,0007,670,400
Cost of Revenue1,294,0001,365,0001,949,000891,000
Gross Profit11,709,0009,864,0007,307,0006,779,400
Operating Expenses
Research Development3,274,0003,543,0002,089,0001,796,300
Selling General and Administrative2,626,0002,459,0002,300,0002,027,900
Non Recurring----
Others----
Total Operating Expenses7,523,0007,725,0006,617,0004,973,500
Operating Income or Loss5,480,0003,504,0002,639,0002,696,900
Income from Continuing Operations
Total Other Income/Expenses Net-1,166,000-1,132,000-616,000-369,500
Earnings Before Interest and Taxes5,480,0003,504,0002,639,0002,696,900
Interest Expense-522,000-500,000-311,000-176,100
Income Before Tax4,314,0002,372,0002,023,0002,327,400
Income Tax Expense1,374,000373,000421,000327,500
Minority Interest----
Net Income From Continuing Ops2,940,0001,999,0001,602,0001,999,900
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,940,0001,999,0001,602,0001,999,900
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares2,940,0001,999,0001,602,0001,999,900